Companies › ARMP

ARMATA PHARMACEUTICALS INC (ARMP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000921114 · EDGAR filings · Updated 2026-07-20

ARMATA PHARMACEUTICALS INC (ARMP) has reported institutional ownership of 10.7%, with 45 institutional managers holding positions valued at $40.2M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-20 — Current report (8-K) filed
• 2026-07-20 — Current report (8-K) filed
• 2026-07-14 — Insider transaction reported (Form 4)
• 2026-07-13 — Current report (8-K) filed
• 2026-07-13 — Employee-plan registration (S-8) filed
• 2026-06-24 — Amended current report (8-K/A) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ARMATA PHARMACEUTICALS INC has 45 institutional holders and institutional ownership of 10.7%.

Insider activity

Insiders reported 6 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

NANO X IMAGING LTD (NNOX) · PYXIS ONCOLOGY INC (PYXS) · SERA PROGNOSTICS INC (SERA) · CARDIFF ONCOLOGY INC (CRDF) · CANTON STRATEGIC HOLDINGS IN (CNTN) · AUNA S A (AUNA)